H
Hospital Ruber Juan Bravo | Neurology Department - Stroke, No-Cardioembolic-Tia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Prasinezumab
Tocilizumab
paclItaxel
blinatumomab
Atezolizumab
Bevacizumab
ABemaciclib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 8 total trials
The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with e...
Enrolling
Parkinson's Disease
Drug: Prasinezumab
Drug: Placebo
This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab...
Active, not recruiting
Parkinsons Disease
Drug: Placebo
Drug: Prasinezumab
This study is open to adults who had an acute stroke caused by a clot blocking a blood vessel in the brain (acute ischemic stroke). This study is for...
Enrolling
Acute Ischemic Stroke
Drug: Tenecteplase
Drug: Standard of care treatment
Trial sponsors
M
F
P
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems